Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-06

Clinical Trial Update: A Randomized Trial of Botulinum Toxin A vs Strabismus Surgery for Esotropia >10 to ≤30PD [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing Botulinum Toxin A with strabismus surgery for esotropia with 10-30 prism diopters, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Esotropia | Phase 3 | Status: NOT_YET_RECRUITING